New Leadership at DWK Life Sciences: Michael Werth Succeeds Armin ReicheBy Mario Cazombo / April 14, 2026 After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board. Read More
Frankenstein’s Index Fund August 6, 2025 / Alternative Investments, Drivers of Value, Economics, General, Investment Topics, Performance Measurement & Evaluation
How GenAI-Powered Synthetic Data Is Reshaping Investment Workflows August 6, 2025 / Artificial Intelligence, Drivers of Value, Future States, General, Investment Topics, Philosophy
